Pomalyst Capsule
Product Images NDC 59572-502

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalyst (NDC 59572-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pomalidomide Chemical Structure (Pomalyst 01)

Chemical structure of pomalidomide, the active ingredient in Pomalyst capsules. The structure shows a complex heterocyclic ring with various functional groups including amide and carbonyl moieties.*

FDA Label Image

Progression Free Survival Based On Irac Review Of Response By Imwg Criteria (Pomalyst 02)

A Kaplan-Meier survival curve comparing progression-free survival over months between two treatment groups labeled HD-DEX and POM+LD-DEX. The y-axis shows the proportion of subjects surviving without progression, and the x-axis represents time in months. The graph includes a risk table showing the number of subjects at risk at various time points.*

FDA Label Image

Kaplan-meier Curve Of Overall Survival (Pomalyst 03)

A Kaplan-Meier survival curve comparing overall survival between two groups: HD-DEX (solid blue line) and POM-LD-DEX (dashed red line). The x-axis represents overall survival in months (0 to 24), and the y-axis shows the proportion of subjects surviving (0 to 1.0). A risk table below indicates the number of subjects at risk at various time points for each group.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 1 mg (21 Count Bottle Label)

Pomalyst 1 mg capsules packaging label showing the brand name, generic name pomalidomide, dosage strength of 1 mg, and quantity of 21 capsules. The label includes storage instructions, manufacturer information for Celgene Corporation, a warning about potential human birth defects, and a barcode. The product is made in Switzerland.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 1 mg (100 Count Bottle Label)

Label for Pomalyst (pomalidomide) capsules, 1 mg strength. The label indicates 100 capsules per package and includes a warning about potential human birth defects. It is manufactured for Celgene Corporation, with storage and handling instructions specifying controlled room temperature. The label also features a barcode and the Celgene logo.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 2 mg (21 Count Bottle Label)

Pomalyst 2 mg capsules label showing the active ingredient pomalidomide. The label includes the warning about potential human birth defects, prescription status (Rx only), and a package count of 21 capsules. Manufactured for Celgene Corporation, with storage instructions and barcode visible. The product is made in Switzerland.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 2 mg (100 Count Bottle Label)

Pomalyst 2 mg capsules label showing the brand name and generic name pomalidomide. The label includes a warning about potential human birth defects, storage temperature instructions, manufacturer Celgene Corporation, and a barcode. The package contains 100 oral capsules made in Switzerland.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 3 mg (21 Count Bottle Label)

Label for Pomalyst (pomalidomide) capsules 3 mg by Celgene Corporation. The label includes a warning about potential human birth defects, storage instructions at 20-25°C with permitted excursions, manufacturer address in Summit, NJ, and states the product is made in Switzerland. The package contains 21 capsules and features a barcode and the NDC number 59572-503-21.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 3 mg (100 Count Bottle Label)

Pomalyst 3 mg capsules packaging label displaying the product name and generic name pomalidomide. The label includes a warning about potential human birth defects, Rx only designation, and a package count of 100 capsules. It notes storage instructions, manufacturer Celgene Corporation, and indicates the product is made in Switzerland. A barcode and Celgene logo are also visible.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 4 mg (21 Count Bottle Label)

Pomalyst 4 mg capsules label, an oral human prescription drug containing pomalidomide. The label indicates 21 capsules per container, warns of potential human birth defects, and states storage conditions between 20°C and 25°C with permitted excursions. Manufactured for Celgene Corporation, Summit, NJ, with production in Switzerland, the label includes the NDC number 59572-504-21 and a barcode.*

FDA Label Image

Pomalyst (pomalidomide) Capsules, 4 mg (100 Count Bottle Label)

Label for Pomalyst (pomalidomide) capsules, 4 mg strength, oral dosage form. The label indicates 100 capsules per package and is manufactured for Celgene Corporation. Storage instructions and a warning about potential human birth defects are included along with a barcode and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.